| The effect of Fingolimod on patients with moderate to severe COVID‐19 S Teymouri, S Pourbayram Kaleybar, SS Hejazian, SM Hejazian, ... Pharmacology Research & Perspectives 11 (1), e01039, 2023 | 11 | 2023 |
| Dysregulation of immunity in COVID-19 and SLE SS Hejazian, SM Hejazian, F Farnood, S Abedi Azar Inflammopharmacology 30 (5), 1517-1531, 2022 | 8 | 2022 |
| Combined systemic inflammatory indexes as reflectors of outcome in patients with COVID‑19 infection admitted to ICU A Tahavvori, R Mosaddeghi-Heris, F Ghanbari Sevari, SMA Alavi, ... Inflammopharmacology 31 (5), 2337-2348, 2023 | 3 | 2023 |
| The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia S Abolhasani, SS Hejazian, V Karpisheh, A Khodakarami, H Mohammadi, ... IUBMB life 75 (3), 257-278, 2023 | 2 | 2023 |
| Injection of intravenous immunoglobulin (IVIg) for the treatment of Coronavirus induced cytokine storm F Farnood, H Valizadeh, K Ansarin, SZ Vahed, SS Hejazian, A Sadeghi, ... Medical Journal of Tabriz University of Medical Sciences 44 (5), 403-415, 2022 | 2 | 2022 |
| Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients N Farzamikia, SM Hejazian, M Haghi, SS Hejazian, S Zununi Vahed, ... Immunogenetics 74 (2), 207-212, 2022 | 2 | 2022 |
| Epidemiology of road traffic accidents in Tabriz municipality: a crosssectional study A Ala, A Aghili, S Ghorbanian, SS Hejazian, A Nahvi, SAM Aghdas Journal of Research in Clinical Medicine 6 (3), 134-138, 2018 | 2 | 2018 |
| Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide A Khodakarami, MA Kashani, A Nazer, AM Kheshti, B Rashidi, ... Cell Communication and Signaling 21 (1), 188, 2023 | 1 | 2023 |
| Factors affecting complications and mortality of stroke patients in stroke care unit. SS Vahdati, A Ala, S Hejazian, ES Hokmabadi, T Majidi, F Ghanbari, ... | 1 | 2022 |
| The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials. SR Taha, A Fazlollahpour-Naghibi, MS Zadeh, K Bagheri, ... Current Pharmaceutical Biotechnology, 2024 | | 2024 |
| Imaging the post-treatment pelvis with gynecologic cancers B Moradi, SS Hejazian, M Tahamtan, H Ghorani, S Karami Abdominal Radiology, 1-16, 2024 | | 2024 |
| Modulatory Effects of Hydatid Cyst Fluid on a Mouse Model of Experimental Autoimmune Encephalomyelitis M Hajizadeh, A Jabbari, A Spotin, SS Hejazian, T Mikaeili Galeh, ... Veterinary Sciences 11 (1), 34, 2024 | | 2024 |
| Codelivery of Nrf 2 siRNA and Cyclophosphamide Inhibits Leukemia Progression A Khodakarami, MA Kashani, A Nazer, AM Kheshti, B Rashidi, ... | | 2023 |
| Circular RNAs as novel biomarkers in glomerular diseases SM Hejazian, Y Rahbar Saadat, SM Hosseiniyan Khatibi, F Farnood, ... Archives of Physiology and Biochemistry, 1-13, 2023 | | 2023 |
| Alzheimer’s disease pathology programmed by gut-derived disparity: A comprehensive understanding of neurodegeneration A Khabbaz, A Hasani, S Sadigh-Eteghad, N Hosseinzadeh, SS Hejazian, ... Authorea Preprints, 2023 | | 2023 |
| Glucocorticoid Receptor Polymorphisms and Avascular Osteonecrosis After Kidney Transplantation J Etemadi, MRJ Nakhjavani, S Sepehri, R Motavalli, SS Hejazian, ... Iranian Journal of Kidney Diseases 17 (2), 86, 2023 | | 2023 |
| The STAT4 SNP (rs7574865) and systemic lupus erythematosus G Bayat, SM Hejazian, E Ahmadian, SS Hejazian, A Khabbazi, SZ Vahed, ... | | 2022 |
Seyyedeh Mina HejazianTabriz University of Medical SciencesVerified email at tbzmed.ac.ir
